BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  MBX Biosciences to Participate in Upcoming March 2026 Investor Conferences

  February 23, 2026

   · 

  2 min read
• Press Releases

  Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

  February 23, 2026

   · 

  1 min read
• Press Releases

  Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

  February 23, 2026

   · 

  1 min read
• Press Releases

  Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

  February 23, 2026

   · 

  1 min read
• Press Releases

  ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences

  February 23, 2026

   · 

  1 min read
• Press Releases

  Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference

  February 23, 2026

   · 

  1 min read
• Press Releases

  Ultima Genomics Introduces the Next Generation of Sequencing at Scale with the Launch of the UG200™ Series and Next Generation Solaris 2.0 Workflows Delivering Higher Output, Better Performance and More Flexible Wafer Configurations

  February 23, 2026

   · 

  9 min read
• Press Releases

  Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer

  February 23, 2026

   · 

  7 min read
• Press Releases

  ITF Therapeutics LLC Announces Multiple Data Presentations at 2026 MDA Clinical and Scientific Conference

  February 23, 2026

   · 

  9 min read
• Press Releases

  AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca’s Durvalumab in the Treatment of Metastatic Pancreatic Cancer

  February 23, 2026

   · 

  5 min read